415 related articles for article (PubMed ID: 29946029)
1. Gentamicin induces
Lincoln V; Cogan J; Hou Y; Hirsch M; Hao M; Alexeev V; De Luca M; De Rosa L; Bauer JW; Woodley DT; Chen M
Proc Natl Acad Sci U S A; 2018 Jul; 115(28):E6536-E6545. PubMed ID: 29946029
[TBL] [Abstract][Full Text] [Related]
2. Gentamicin Induces Laminin 332 and Improves Wound Healing in Junctional Epidermolysis Bullosa Patients with Nonsense Mutations.
Kwong A; Cogan J; Hou Y; Antaya R; Hao M; Kim G; Lincoln V; Chen Q; Woodley DT; Chen M
Mol Ther; 2020 May; 28(5):1327-1338. PubMed ID: 32222156
[TBL] [Abstract][Full Text] [Related]
3. Laminin-5 mutational analysis in an Italian cohort of patients with junctional epidermolysis bullosa.
Posteraro P; De Luca N; Meneguzzi G; El Hachem M; Angelo C; Gobello T; Tadini G; Zambruno G; Castiglia D
J Invest Dermatol; 2004 Oct; 123(4):639-48. PubMed ID: 15373767
[TBL] [Abstract][Full Text] [Related]
4. Novel compound heterozygous mutation in LAMC2 genes (c.79G>A and 382insT) in Herlitz junctional epidermolysis bullosa.
Jeon IK; Kim SE; Kim SC
J Dermatol; 2014 Apr; 41(4):322-4. PubMed ID: 24533970
[TBL] [Abstract][Full Text] [Related]
5. Laminin 5 genes and Herlitz junctional epidermolysis bullosa: novel mutations and polymorphisms in the LAMB3 and LAMC2 genes. Mutations in brief no. 190. Online.
Kon A; Pulkkinen L; Hara M; Tamai K; Tagami H; Hashimoto I; Uitto J
Hum Mutat; 1998; 12(4):288. PubMed ID: 10660342
[TBL] [Abstract][Full Text] [Related]
6. Molecular and Clinical Outcomes After Intravenous Gentamicin Treatment for Patients With Junctional Epidermolysis Bullosa Caused by Nonsense Variants.
Mosallaei D; Hao M; Antaya RJ; Levian B; Kwong A; Cogan J; Hamilton C; Schwieger-Briel A; Tan C; Tang X; Woodley DT; Chen M
JAMA Dermatol; 2022 Apr; 158(4):366-374. PubMed ID: 35234826
[TBL] [Abstract][Full Text] [Related]
7. Predominance of the recurrent mutation R635X in the LAMB3 gene in European patients with Herlitz junctional epidermolysis bullosa has implications for mutation detection strategy.
Pulkkinen L; Meneguzzi G; McGrath JA; Xu Y; Blanchet-Bardon C; Ortonne JP; Christiano AM; Uitto J
J Invest Dermatol; 1997 Aug; 109(2):232-7. PubMed ID: 9242513
[TBL] [Abstract][Full Text] [Related]
8. CRISPR/Cas9-Mediated In Situ Correction of LAMB3 Gene in Keratinocytes Derived from a Junctional Epidermolysis Bullosa Patient.
Benati D; Miselli F; Cocchiarella F; Patrizi C; Carretero M; Baldassarri S; Ammendola V; Has C; Colloca S; Del Rio M; Larcher F; Recchia A
Mol Ther; 2018 Nov; 26(11):2592-2603. PubMed ID: 30122422
[TBL] [Abstract][Full Text] [Related]
9. Herlitz junctional epidermolysis bullosa: diagnostic features, mutational profile, incidence and population carrier frequency in the Netherlands.
Yuen WY; Lemmink HH; van Dijk-Bos KK; Sinke RJ; Jonkman MF
Br J Dermatol; 2011 Dec; 165(6):1314-22. PubMed ID: 21801158
[TBL] [Abstract][Full Text] [Related]
10. A homozygous nonsense mutation in the alpha 3 chain gene of laminin 5 (LAMA3) in lethal (Herlitz) junctional epidermolysis bullosa.
Kivirikko S; McGrath JA; Baudoin C; Aberdam D; Ciatti S; Dunnill MG; McMillan JR; Eady RA; Ortonne JP; Meneguzzi G
Hum Mol Genet; 1995 May; 4(5):959-62. PubMed ID: 7633458
[TBL] [Abstract][Full Text] [Related]
11. In vivo restoration of laminin 5 beta 3 expression and function in junctional epidermolysis bullosa.
Robbins PB; Lin Q; Goodnough JB; Tian H; Chen X; Khavari PA
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5193-8. PubMed ID: 11296269
[TBL] [Abstract][Full Text] [Related]
12. Genetic bases of severe junctional epidermolysis bullosa presenting spontaneous amelioration with aging.
Gache Y; Allegra M; Bodemer C; Pisani-Spadafora A; de Prost Y; Ortonne JP; Meneguzzi G
Hum Mol Genet; 2001 Oct; 10(21):2453-61. PubMed ID: 11689492
[TBL] [Abstract][Full Text] [Related]
13. Herlitz junctional epidermolysis bullosa.
Laimer M; Lanschuetzer CM; Diem A; Bauer JW
Dermatol Clin; 2010 Jan; 28(1):55-60. PubMed ID: 19945616
[TBL] [Abstract][Full Text] [Related]
14. Lack of K140 immunoreactivity in junctional epidermolysis bullosa skin and keratinocytes associates with misfolded laminin epidermal growth factor-like motif 2 of the β3 short arm.
Condorelli AG; Fortugno P; Cianfarani F; Proto V; Di Zenzo G; Didona B; Zambruno G; Castiglia D
Br J Dermatol; 2018 Jun; 178(6):1416-1422. PubMed ID: 28561256
[TBL] [Abstract][Full Text] [Related]
15. Laminin 332 in junctional epidermolysis bullosa.
Kiritsi D; Has C; Bruckner-Tuderman L
Cell Adh Migr; 2013; 7(1):135-41. PubMed ID: 23076207
[TBL] [Abstract][Full Text] [Related]
16. Keratinocytes from junctional epidermolysis bullosa do adhere and migrate on the basement membrane protein nicein through alpha 3 beta 1 integrin.
Verrando P; Lissitzky JC; Sarret Y; Winberg JO; Gedde-Dahl T; Schmitt D; Bruckner-Tuderman L
Lab Invest; 1994 Oct; 71(4):567-74. PubMed ID: 7967512
[TBL] [Abstract][Full Text] [Related]
17. Laminin 5 mutations in junctional epidermolysis bullosa: molecular basis of Herlitz vs. non-Herlitz phenotypes.
Nakano A; Chao SC; Pulkkinen L; Murrell D; Bruckner-Tuderman L; Pfendner E; Uitto J
Hum Genet; 2002 Jan; 110(1):41-51. PubMed ID: 11810295
[TBL] [Abstract][Full Text] [Related]
18. Mutations in the 180-kD bullous pemphigoid antigen (BPAG2), a hemidesmosomal transmembrane collagen (COL17A1), in generalized atrophic benign epidermolysis bullosa.
McGrath JA; Gatalica B; Christiano AM; Li K; Owaribe K; McMillan JR; Eady RA; Uitto J
Nat Genet; 1995 Sep; 11(1):83-6. PubMed ID: 7550320
[TBL] [Abstract][Full Text] [Related]
19. Novel and recurrent mutations in the laminin-5 genes causing lethal junctional epidermolysis bullosa: molecular basis and clinical course of Herlitz disease.
Mühle C; Jiang QJ; Charlesworth A; Bruckner-Tuderman L; Meneguzzi G; Schneider H
Hum Genet; 2005 Jan; 116(1-2):33-42. PubMed ID: 15538630
[TBL] [Abstract][Full Text] [Related]
20. Maternal uniparental disomy of chromosome 1 with reduction to homozygosity of the LAMB3 locus in a patient with Herlitz junctional epidermolysis bullosa.
Pulkkinen L; Bullrich F; Czarnecki P; Weiss L; Uitto J
Am J Hum Genet; 1997 Sep; 61(3):611-9. PubMed ID: 9326326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
